Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
4.
Neuropediatrics ; 31(4): 214-7, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11071149

RESUMO

An 8-year old girl with a not previously described type of complicated hereditary spastic paraplegia (HSP) is presented. Spasticity in her lower limbs had already been recognized during infancy and worsened progressively. Severe delay in mental development was observed. Peripheral neuropathy and optic atrophy developed at 5 years of age. On brain magnetic resonance imaging, an abnormally thin corpus callosum was observed. Involvement of the fasciculus gracilis was suggested by somatosensory evoked potentials. To our knowledge, there has been no reported case of complicated HSP with peripheral neuropathy, optic atrophy and mental retardation so far. We postulate that our patient is a sporadic case of not previously described complicated HSP.


Assuntos
Deficiência Intelectual/complicações , Atrofia Óptica/complicações , Paraplegia/complicações , Doenças do Sistema Nervoso Periférico/complicações , Agenesia do Corpo Caloso , Encéfalo/patologia , Criança , Potenciais Somatossensoriais Evocados/fisiologia , Feminino , Humanos , Imageamento por Ressonância Magnética , Paraplegia/diagnóstico , Índice de Gravidade de Doença
5.
Biochem Biophys Res Commun ; 273(1): 164-9, 2000 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-10873580

RESUMO

Previously, we showed that several minor macromolecular glycolipids accounting for less than 5% of the lipoteichoic acid (LTA) fraction from Enterococcus hirae ATCC 9790 possess cytokine-inducing activity, whereas the purified LTA does not. In other words, the immunobiological activity of the LTA fraction reported in the 1980s was not attributable to LTA itself, but to other glycolipids coexisting in the fraction. In the present study, we improved the procedure of separation of the active glycolipids and evaluated their effects on cellular activation. The immunobiologically active glycolipids were separated from the crude glycolipid fraction obtained by hot phenol-water extraction of the cells. The total yield of active glycolipids was about fivefold higher than that separated by the previous method. Interleukin-6-inducing activities of the active glycolipids from 1,25-dihydroxy vitamin D(3)-differentiated human monocytic leukemia cells, THP-1, were inhibited by anti-CD14 mAbs in a dose-dependent manner. Macrophages from Toll-like receptor (TLR)-2-deficient or -4-deficient mice completely lacked the ability to produce tumor necrosis factor-alpha on stimulation with active glycolipids. These observations indicated that the cellular activation by the active glycolipids from E. hirae is mediated by CD14 and by both TLR2 and TLR4.


Assuntos
Citocinas/biossíntese , Proteínas de Drosophila , Enterococcus/química , Glicolipídeos/isolamento & purificação , Glicolipídeos/farmacologia , Regulação para Cima/efeitos dos fármacos , Animais , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/farmacologia , Calcitriol/farmacologia , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Humanos , Interleucina-18/biossíntese , Interleucina-6/biossíntese , Receptores de Lipopolissacarídeos/imunologia , Receptores de Lipopolissacarídeos/metabolismo , Lipopolissacarídeos/farmacologia , Macrófagos/citologia , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Glicoproteínas de Membrana/deficiência , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/fisiologia , Camundongos , Camundongos Knockout , Receptores de Superfície Celular/deficiência , Receptores de Superfície Celular/genética , Receptores de Superfície Celular/fisiologia , Receptor 2 Toll-Like , Receptor 4 Toll-Like , Receptores Toll-Like , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/biossíntese
6.
Biochem Biophys Res Commun ; 257(2): 327-32, 1999 Apr 13.
Artigo em Inglês | MEDLINE | ID: mdl-10198211

RESUMO

Bacterial lipopolysaccharide (LPS) induces the production of various inflammatory cytokines and the inducibility is considered attributable to the glycolipid part of LPS called lipid A. We report an in vitro model in which lipid A is not necessarily a minimal structure for the LPS activity. Vitamin D3-differentiated THP-1 cells, cultured human monocytic leukemia cells, produced a high level of interleukin-6 (IL-6) by stimulating LPS from Escherichia coli O111:B4, but not by stimulating synthetic E. coli-type lipid A (compound 506), E. coli Re mutant LPS (ReLPS), or alkali-treated LPS. The induction by LPS was inhibited by the anti-CD14 antibodies or by the synthetic lipid A precursor (compound 406). An alkali-treated LPS or compound 506 partially inhibited the LPS-induced IL-6 production. These facts suggest that lipid A alone is not sufficient for the IL-6-inducing activity, but the polysaccharide part in LPS contributes or acts as a co-factor for activation of differentiated THP-1 cells.


Assuntos
Calcitriol/farmacologia , Interleucina-6/biossíntese , Lipídeo A/farmacologia , Lipopolissacarídeos/farmacologia , Monócitos/citologia , Álcalis/farmacologia , Anticorpos Monoclonais/farmacologia , Células Sanguíneas/efeitos dos fármacos , Células Sanguíneas/metabolismo , Proteínas Sanguíneas/farmacologia , Adesão Celular/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Glicolipídeos/química , Glicolipídeos/farmacologia , Humanos , Lipídeo A/análogos & derivados , Lipídeo A/química , Receptores de Lipopolissacarídeos/imunologia , Receptores de Lipopolissacarídeos/fisiologia , Lipopolissacarídeos/antagonistas & inibidores , Lipopolissacarídeos/química , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , Células Tumorais Cultivadas
7.
Biochim Biophys Acta ; 1294(2): 153-8, 1996 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-8645733

RESUMO

D-Aspartate oxidase (EC 1.4.3.1), which is highly specific to D-aspartate, was inducibly produced by a yeast strain which was isolated from soil and identified as Cryptococcus humicolus UJ1. The enzyme was purified to homogeneity as indicated on SDS-polyacrylamide gel electrophoresis. The molecular mass of the monomer subunit was determined to be 40 kDa. The native enzyme was suggested to be a homotetramer by its behavior on gel filtration. The enzyme was shown to be a flavoprotein by its absorption spectral properties, and the flavin was found to be tightly, but not covalently, bound FAD. The purified preparation had a specific activity of 76.1 mumol/min per mg protein with D-aspartate as substrate. Optimum pH was 7.5 and optimum temperature was around 35 degrees C. D-Glutamate was a very poor substrate for the enzyme. N-Methyl-D-aspartate was better than D-glutamate as substrate but markedly poorer than D-aspartate. Malonate was the most effective competitive inhibitor of the compounds tested. The N-terminal amino-acid sequence of the enzyme showed a significant homology with those of D-aspartate oxidases from beef kidney and Octopus vulgaris and those of D-amino-acid oxidases from various sources.


Assuntos
Aminoácido Oxirredutases/isolamento & purificação , Aminoácido Oxirredutases/metabolismo , Cryptococcus/enzimologia , Aminoácido Oxirredutases/química , Sequência de Aminoácidos , Aminoácidos/metabolismo , Animais , Bovinos , Cromatografia em Gel , Cromatografia por Troca Iônica , Sequência Consenso , Cryptococcus/crescimento & desenvolvimento , D-Aspartato Oxidase , Inibidores Enzimáticos/farmacologia , Humanos , Rim/enzimologia , Dados de Sequência Molecular , Peso Molecular , Octopodiformes , Homologia de Sequência de Aminoácidos , Espectrofotometria , Especificidade por Substrato , Suínos
8.
No To Hattatsu ; 27(4): 315-9, 1995 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-7612294

RESUMO

A 1-year-and-9-months old boy with gait disturbance during the 3rd week of Kawasaki disease (KD) was described. He had been previously healthy, and developed high fever and rash. The diagnosis of KD was based on 5 of 6 major criteria on the 3rd clinical day. He was initially treated with intravenous gamma-globulin 400 mg/kg/day for five days. On the 17th clinical day, the patient developed gait disturbance after most clinical signs disappeared. His gait was wide- based and unstable. Generalized hypotonia with poor traction response was also seen. Pyramidal tract signs including exaggerated patellar and Achilles tendon reflexes and positive bilateral Mendel-Bechterew reflex were presented. Cerebrospinal fluid was normal. Brain CT, MRI, and 123I-IMP SPECT images were normal without broad hemorrhage or infarction of the cerebral parenchyma. Gait disturbance recovered spontaneously within one month without any sequelae.


Assuntos
Doenças do Sistema Nervoso Central/complicações , Marcha , Transtornos dos Movimentos/etiologia , Síndrome de Linfonodos Mucocutâneos/complicações , Doenças do Sistema Nervoso Central/fisiopatologia , Humanos , Lactente , Masculino , Síndrome de Linfonodos Mucocutâneos/fisiopatologia , Tratos Piramidais/fisiopatologia
9.
Neuroreport ; 6(8): 1085-8, 1995 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-7662883

RESUMO

In order to assess the characteristics of the older astrocyte, we obtained long-term cultured rat astrocytes (20 months) and examined the features of protein expression in relation to neuronal interaction. In short-term cultured astrocytes, NCAM expressed strongly in contrast to weak expression of laminin by both immunocytochemical and ELISA assay. On the contrary, in long-term cultured astrocytes, a marked decrease of NCAM expression was observed along with increased laminin expression compared with short-term cultured astrocytes. The long-term cultured astrocytes remained positive to anti-GFAP antibody and showed a much lower ability to interact with neurones than the short-term cultured astrocytes. NCAM may be one of the responsible molecules related to the astrocyte-neurone interaction in the developing and ageing nervous system.


Assuntos
Astrócitos/metabolismo , Moléculas de Adesão Celular Neuronais/biossíntese , Neurônios/fisiologia , Animais , Adesão Celular/genética , Divisão Celular , Células Cultivadas , Senescência Celular/fisiologia , Ensaio de Imunoadsorção Enzimática , Feminino , Imunofluorescência , Expressão Gênica , Proteína Glial Fibrilar Ácida/biossíntese , Laminina/biossíntese , Ratos , Ratos Wistar , Fatores de Tempo
10.
No To Hattatsu ; 24(5): 462-8, 1992 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-1389330

RESUMO

We studied the clinical usefulness of I123-IMP SPECT in 50 pediatric patients with CNS disorders, which were categorized into the convulsive disorder group (n = 20), the cerebrovascular disorder group (n = 10), the acute encephalopathy or CNS infection group (n = 10), the metabolic or degenerative disorder group (n = 6), the congenital abnormality group (n = 2) and the migraine group (n = 2). The findings obtained were compared with those of cranial CT. I123-IMP SPECT revealed abnormal findings in 45 out of the 50 patients (90%), although cranial CT showed abnormal findings in only 24 patients (48%). This difference was statistically significant (p less than 0.01). In all groups except the migraine, we could find abnormal findings in more than 90% of the patients. Out of 28 patients without focal findings on the initial CT scanning, I123-IMP SPECT showed focal abnormalities in 26 patients (93%). Moreover in many patients with focal neurological abnormalities, we found focal abnormalities of I123-IMP SPECT related with neurological abnormalities of the patients. From these findings, we think I123-IMP SPECT might be better to CT scanning in examining a localized lesion. It was found that in many patients with focal abnormalities in CT scanning, I123-IMP SPECT showed larger abnormalities in CT scanning. By using I123-IMP SPECT we might be able to study the blood perfusional state surrounding the abnormal area shown by CT. In 3 patients with acute cerebrovascular disorders, I123-IMP SPECT revealed abnormal findings 3 to 11 days earlier than cranial CT.I123-IMP SPECT might be useful for early recognition of the pathological state.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Anfetaminas , Encéfalo/diagnóstico por imagem , Radioisótopos do Iodo , Tomografia Computadorizada de Emissão de Fóton Único , Fatores Etários , Doenças do Sistema Nervoso Central/diagnóstico por imagem , Doenças do Sistema Nervoso Central/patologia , Criança , Pré-Escolar , Humanos , Lactente , Iofetamina , Tomografia Computadorizada por Raios X
11.
Epilepsia ; 32(2): 279-83, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1900791

RESUMO

We studied the clinical efficacy of allopurinol as add-on therapy in 31 patients with intractable epilepsy. When administered for a short time, allopurinol was effective in 17 patients (55%); 8 were seizure-free, 8 had 75% decrease in seizure frequency, and 1 had greater than 50% decrease. Allopurinol was most effective in patients with localization-related epilepsy, especially in secondarily generalized tonic-clonic seizures. Allopurinol was not as effective in patients with Lennox syndrome or West syndrome, or in severe myoclonic epilepsy in infants. When allopurinol was administered greater than 1 year, its initial effectiveness continued in 8 of 14 patients who exhibited initial improvement. In 2 of the remaining 6 patients, the initial improvement disappeared during the course of treatment but control was regained by increasing the dosage of allopurinol. Mild side effects were observed in 4 patients (13%): drowsiness in 3 and abdominal pain in 1. Allopurinol may be a useful antiepileptic drug (AED), and a double-blind placebo-controlled trial should be performed.


Assuntos
Alopurinol/uso terapêutico , Epilepsia/tratamento farmacológico , Adolescente , Adulto , Alopurinol/administração & dosagem , Criança , Pré-Escolar , Esquema de Medicação , Epilepsias Mioclônicas/tratamento farmacológico , Epilepsia Tipo Ausência/tratamento farmacológico , Epilepsia do Lobo Temporal/tratamento farmacológico , Feminino , Seguimentos , Humanos , Lactente , Masculino , Espasmos Infantis/tratamento farmacológico
12.
Nihon Jinzo Gakkai Shi ; 32(4): 409-14, 1990 Apr.
Artigo em Japonês | MEDLINE | ID: mdl-2198364

RESUMO

We evaluated a new automated biopsy device for percutaneous renal biopsies under ultrasound guidance, which was recently introduced in Japan for prostate biopsies. This device (Biopty-Gun: Bard Biopty Instrument Uppsala, Sweden) employs a Tru-Cut type smaller needle (18 gauge). We were able to obtain one or two renal tissues in all 57 cases with great ease and in little time. The length of specimen was sufficient (5-17 mm), but the width was thinner than the samples with the Vim-Silverman or Tru-Cut needles. We could achieve a definitive pathological diagnosis in 54 of 57 cases (94.7%), but now, we try to obtain two pieces of tissue for taking more adequate tissue. Only three patients had perirenal hematomas noted by computerized tomography or ultrasonography. We believe that this new automated technique offers a safer and more effective means of obtaining renal tissue.


Assuntos
Biópsia por Agulha/métodos , Rim/patologia , Adolescente , Adulto , Biópsia por Agulha/instrumentação , Criança , Pré-Escolar , Estudos de Avaliação como Assunto , Feminino , Humanos , Nefropatias/diagnóstico , Nefropatias/patologia , Masculino , Pessoa de Meia-Idade , Ultrassonografia
14.
J Child Neurol ; 3(4): 250-7, 1988 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3143757

RESUMO

Breath tests using fatty acids labeled with a stable isotope (carbon 13) were carried out on epileptic patients treated with valproic acid in order to detect abnormal fatty acid metabolism. The patients were given 13C-octanoic acid or 13C-palmitic acid orally, and expired air was collected at appropriate intervals for the analysis of 13CO2 content by a mass spectrometer. Eight patients were tested in the palmitic acid breath test and nine patients in the octanoic acid breath test. Controls for these tests were patients treated with antiepileptic drugs other than valproic acid and unmedicated cerebral palsy patients. In the valproic acid-treated group, 13C recovery was reduced by 56% in seven hours on the 13C-palmitic acid breath test, while the octanoic acid breath test showed a 52% reduction in one hour. This suppression of fatty acid oxidation was significantly correlated with dose of valproic acid in both tests. No influence of other drugs was detected, and the effect of administered carnitine was not conclusive. This study demonstrates the usefulness of 13C-labeled fatty acid breath tests in clinical practice.


Assuntos
Epilepsia/tratamento farmacológico , Ácidos Graxos/metabolismo , Ácido Valproico/uso terapêutico , Adolescente , Caprilatos/metabolismo , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Epilepsia/metabolismo , Feminino , Humanos , Masculino , Ácidos Palmíticos/metabolismo , Ácido Valproico/sangue
17.
Brain Res ; 394(1): 31-6, 1986 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3530381

RESUMO

Studies on the presence of the brain-specific alpha 2-glycoprotein in cultures of newborn rat brain cells revealed that a population of glial precursor cells expressed this antigen at an early stage of development. This cell population consisted of small, phase-dark cells that proliferated in culture and occupied the surface of a layer of flat epithelial-like astrocytes. The latter cell type did not react with the antibodies. The number of alpha 2-glycoprotein positive cells gradually decreased from a high concentration of 88% of the total overlying cells at 6 days of culture to 44% at 23 days. The morphological heterogeneity of the overlying cells was noticeable after 10 days in culture as clusters of cells with elaborate processes started to develop. alpha 2-Glycoprotein was found to be concentrated in these structures. A glioma cell line (C-6 glia) which represents a unique in vitro model for the glial progenitor cells, was also found to express this glycoprotein antigen.


Assuntos
Encéfalo/citologia , Glicoproteínas/metabolismo , Neuroglia/metabolismo , Células-Tronco/metabolismo , Animais , Encéfalo/metabolismo , Células Cultivadas , Glicoproteínas/análise , Técnicas Imunoenzimáticas , Neuroglia/análise , Neuroglia/classificação , Ratos
18.
J Biochem ; 98(6): 1669-79, 1985 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2419314

RESUMO

AY-9944 (trans-1,4-bis(2-chlorobenzylaminoethyl)cyclohexane dihydrochloride), a cationic amphiphilic drug, caused a rapid, irreversible and dose-dependent reduction of acid sphingomyelinase activity in normal human fibroblasts without changing the activities of other lysosomal hydrolases tested. Examinations of activities against synthetic substrates and of the pH-dependency of sphingomyelinase in the drug-treated cells also suggested that the reduction of activity was specific to acid sphingomyelinase. Such a specific reduction was also found with 12 other cationic amphiphilic drugs, most of which have been shown to be inducers of experimental phospholipidosis in animals and/or cultured cells. These results strongly suggest that acid sphingomyelinase is involved in the process of drug-induced lipidosis. The reduction of acid sphingomyelinase seemed not to be due to direct inhibition by these drugs, a specific loss of the enzyme into the culture medium, the presence of inhibitor in the drug-treated cells, or impaired synthesis of the enzyme. There was no indication that changes in the catalytic properties of the enzyme, or changes in the requirement of detergents for its activity occurred in the cell. These results suggest that AY-9944 and other cationic amphiphilic drugs may cause the reduction of acid sphingomyelinase activity by inducing an increased rate of degradation of the enzyme or by causing an irreversible inactivation via some undetected factor.


Assuntos
Cicloexanos/farmacologia , Fibroblastos/enzimologia , Diester Fosfórico Hidrolases/análise , Esfingomielina Fosfodiesterase/análise , Dicloridrato de trans-1,4-Bis(2-clorobenzaminometil)ciclo-hexano/farmacologia , Cátions/farmacologia , Cloroquina/farmacologia , Depressão Química , Dibenzazepinas/farmacologia , Dibucaína/farmacologia , Indução Enzimática/efeitos dos fármacos , Humanos , Concentração de Íons de Hidrogênio , Lisossomos/enzimologia , Masculino , Fenotiazinas/farmacologia , Esfingomielina Fosfodiesterase/biossíntese , Sulfonamidas/farmacologia
20.
Steroids ; 39(6): 631-41, 1982 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7157435

RESUMO

In order to find an artificial internal standard compound for quantitative determination of bile acids by gas chromatography, 7 alpha,12 alpha-, 7 alpha, 12 beta-, 7 beta, 12 alpha- and 7 beta,12 beta-dihydroxy-5 beta-cholan-24-oic acids were chemically synthesized with cholic acid (1) as the first starting material. The gas chromatographic retention time of 7 beta,12 beta-dihydroxy-5 beta-cholan-24-oic acid (beta beta-isomer) was more different from that of natural bile acids than the other isomers. Moreover, beta beta-isomer was extracted in the same fraction as the bile acids from urine, and no urinary substance had the same retention time as beta beta-isomer. No artifact was produced from beta beta-isomer during the analysis procedure. It was concluded that the beta beta-isomer is an internal standard compound with certain advantages for the quantitative determination of bile acids in urine by gas chromatography, irrespective of the recovery rate during the analysis procedure.


Assuntos
Ácidos e Sais Biliares/análise , Ácido Desoxicólico , Cromatografia Gasosa/métodos , Humanos , Padrões de Referência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...